FisherVista
@fishervista
24176 articles
Articles

Santos Muscle Nutrition Announces U.S. Expansion Through Walmart.com Launch
Dutch sports nutrition brand Santos Muscle Nutrition plans expanded U.S. access through Walmart.com.
April 2, 2026Read the full article
Retail Veteran Mitch Gould Offers Roadmap for Sports Nutrition Brands Entering Competitive U.S. Market
Industry veteran behind Evolution of Distribution shares insights on what separates successful sports nutrition brands in the U.S.
April 2, 2026Read the full article

Ares Strategic Mining Establishes New Investor Relations Team Following $10 Million Funding
Ares Strategic Mining Inc. has introduced a new Investor Relations Team following the company's recent $10 million funding. This strategic enhancement enables the company to better support its expanding shareholder base and position for future growth, including a potential uplisting to the NASDAQ.The new team appointments i...
April 2, 2026Read the full article

Carmed Pharmaceuticals Expands U.S. Distribution Through Amazon Launch of Research-Based Botanical Formulations
Standardized carvacrol formulations to be available soon on Amazon as Carmed broadens U.S. distribution.
April 2, 2026Read the full article

Symbio's Temecula Expansion Highlights California's Clean Energy Leadership and Regional Economic Strategy
The SoCal Wine Country Economic Development Coalition has highlighted Symbio's expansion in Temecula as a significant development in clean energy innovation and regional economic growth. Symbio, a leading hydrogen fuel cell company, established its North American headquarters in Temecula two years ago, marking a strategic m...
April 1, 2026Read the full article

Leonteq Shareholders Approve All Board Proposals at 2026 Annual General Meeting
Leonteq AG shareholders approved all proposals presented by the Board of Directors at the company's 2026 Annual General Meeting held in Zurich. The meeting saw attendance representing approximately 64% of issued shares, with 102 shareholders present in person and an independent proxy representing an additional 1,152 shareho...
April 1, 2026Read the full article

LION E-Mobility AG Reports Strong Financial Turnaround and Growth in 2025
LION E-Mobility AG, a manufacturer of battery packs for electric mobility and energy storage solutions, reported a substantial financial improvement for the 2025 fiscal year. According to preliminary figures, total revenue reached EUR 28.3 million, representing a 68% increase from EUR 16.9 million in 2024. The company's EBI...
April 1, 2026Read the full article

Springer Nature CFO Alexandra Dambeck to Depart by End of 2026
Alexandra Dambeck has decided to step down from her role as Chief Financial Officer of Springer Nature and as a member of the Management Board to pursue a new external opportunity. Her departure is scheduled for the fourth quarter of 2026, with her specific end date to be confirmed. The company has initiated the process of ...
April 1, 2026Read the full article

Cardio Diagnostics Advances Precision Cardiovascular Medicine with AI-Powered Testing Platform
Cardio Diagnostics Holdings, trading on NASDAQ as CDIO, is positioning itself as a significant player in precision cardiovascular medicine through an artificial intelligence-powered platform that analyzes epigenetic and genetic biomarkers from blood samples. The company's approach represents a shift from traditional diagnos...
April 1, 2026Read the full article

Peapack Private Promotes Lisa Brandi to Senior Vice President, Treasury Management Sales
Peapack-Gladstone Financial Corporation and Peapack Private Bank & Trust announced the promotion of Lisa Brandi to Senior Vice President, Treasury Management Sales. This internal advancement signals the bank's continued investment in its commercial banking leadership and specialized financial services for business clients.B...
April 1, 2026Read the full article

Soligenix Reports 2025 Progress on Rare Disease Pipeline Including Phase 3 CTCL Trial
Soligenix reported 2025 results highlighting progress across its rare disease pipeline, with particular focus on advancing its Phase 3 FLASH2 trial of HyBryte for cutaneous T-cell lymphoma. The company expects interim analysis in the second quarter of 2026 and top-line results in the second half of the year, marking critica...
April 1, 2026Read the full article

Datavault AI Launches $100 Million Copper Tokenization Initiative with Coppercore
Datavault AI has announced a definitive agreement with Coppercore Inc. to digitize and tokenize copper resources through its proprietary blockchain platform. The initiative targets creating $100 million or more in Coppercoin digital tokens, with each token representing five pounds of in-ground copper and pricing linked to C...
April 1, 2026Read the full article

LIXTE Biotechnology's Clinical-Stage PP2A Inhibitor LB-100 Shows Potential to Transform Cancer Treatment
LIXTE Biotechnology Holdings (NASDAQ: LIXT) has positioned itself at the forefront of cancer research with LB-100, the world's only clinical-stage inhibitor of protein phosphatase 2A (PP2A). This development represents a significant advancement in oncology, offering a novel approach that could enhance the effectiveness of e...
April 1, 2026Read the full article

CMX Gold & Silver Corp. Advances Exploration at Idaho's Clayton Silver Project, Citing Multi-Vein Potential
CMX Gold & Silver Corp., an exploration-stage company trading as CSE: CXC and OTC: CXXMF, is advancing exploration at its flagship Clayton Silver project in Idaho. The 1,028-acre property holds 29 patented mining claims, two patented mill sites, and 20 unpatented claims. The Clayton mine was historically the most active und...
April 1, 2026Read the full article

Nightfood Holdings Completes Acquisition of AI-Powered Beverage Robotics Platform
Nightfood Holdings Inc., operating as TechForce Robotics, has completed a comprehensive intellectual property acquisition of the BIM-E Autonomous Beverage Robotics Platform. This transaction occurs as the broader AI-driven service robotics market accelerates from prototype development toward real-world, revenue-generating d...
April 1, 2026Read the full article

Great Estate Blockchain Reports Strong 2025 Revenue Growth Amid Strategic Uncertainty
Great Estate Blockchain Inc., formerly known as Vaycaychella Inc., reported over $2.0 million in revenue with close to $500,000 in operating profit for the fiscal year 2025, representing approximately 300% revenue growth compared to the same period last year. This financial performance highlights the company's rapid expansi...
April 1, 2026Read the full article

Soligenix Advances Clinical Credibility with HyBryte Research Publication in Peer-Reviewed Journal
The publication of clinical research in peer-reviewed journals remains a critical milestone in drug development, offering independent validation and broader visibility for emerging therapies. Soligenix (NASDAQ: SNGX) recently reached such a milestone with the publication of a clinical summary of its HyBryte(TM) therapy, rei...
April 1, 2026Read the full article

HR.com Announces 2026 Talent Assessment and Screening Award Winners
HR award honors innovative solutions that empower employers to improve hiring outcomes, enhance candidate evaluation, and strengthen talent pipelines.
April 1, 2026Read the full article

Ucore Rare Metals Accelerates Production Plans for Critical Magnet Materials Amid Supply Concerns
Recent analysis highlights significant vulnerabilities in the supply chain for specialized rare earth elements samarium and gadolinium, driven by concentrated production sources and escalating global demand. Ucore Rare Metals Inc. is responding by accelerating commercial development of its processing capabilities for these ...
April 1, 2026Read the full article

Massimo Group Reports 2025 Financial Results with Significant Margin Expansion Despite Revenue Decline
Massimo Group reported financial results for the fiscal year ended December 31, 2025, demonstrating a substantial improvement in profitability metrics despite a decline in overall revenue. The company's gross margin expanded to approximately 37.5%, a significant increase from 29.7% in 2024, driven primarily by product mix o...
April 1, 2026Read the full article

Scientists Overcome 50-Year Production Barrier for Key Cancer Drug
Scientists have solved a production challenge that has hindered doxorubicin manufacturing since the 1970s by engineering bacteria that generate 180% more of the critical chemotherapy drug than current methods achieve. The breakthrough addresses molecular bottlenecks that forced pharmaceutical companies to rely on expensive,...
April 1, 2026Read the full article
